Igrene (ABI) Q4 23/24 earnings summary

Executive summary

• Net loss after financial items was -5,202 KSEK for the year, compared to -3,203 KSEK the previous year.

• Strategic focus is on extracting carbon and hydrogen from methane deposits in Siljansringen, with new technology partnerships and EU support sought.

• No dividend proposed for 2023/2024.

Financial highlights

• Revenue for the year was 255 KSEK, mainly from asset sales, compared to 3 KSEK last year.

• Operating loss was -5,204 KSEK, up from -2,967 KSEK year-over-year.

• Earnings per share was -0.10 SEK, compared to -0.06 SEK last year.

• Cash and cash equivalents at year-end were 972 KSEK, down from 4,210 KSEK.

• Equity at year-end was 19,002 KSEK, down from 24,205 KSEK.

Outlook and guidance

• Plans to apply for environmental permits in autumn 2024 for a demonstration plant producing carbon and hydrogen.

• Ongoing efforts to secure EU funding for technology development and demonstration facility.

• Anticipates constructive dialogue with authorities regarding use of biogenic methane.